WHO identifies problems at Sputnik V factory
WHO said they have discovered problems at a sputnik V vaccine in South Russia, Moskva claims they have been resolved.
Russia is pushing to WHO approved Vaccine Sputnik V, produced by the Russian Gamaleya Research Institute, which has been now used in 40 countries such as Argentina, India, Iran, Kenya, Mexico, Pakistan, Philippines and UAE.
Sputnik V vaccine lots to Guatemala on June 16.
WHO today announced a summary report of his preliminary findings, detailing 6 issues found in the visit from May 31 to June 4 at Pharmstandard Ufa Vitamin Factory in southern Russia
Insoles have identified issues related to traceability and identifying vaccines.
WHO said the factory was informed of these findings.
WHO has licensed Astrazeneca vaccines, Pfizer-Biontech, Moderna, Johnson & Johnson, Sinopharm and Sinovac.
Comments
Post a Comment